1 European Center for Disease Prevention and Control. Monitoring implementation of the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2018 progress report.
https://www.ecdc.europa.eu/sites/default/files/documents/HIV-continuum-of-care-monitoring-dublin-declaration-progress-report-2018.pdf: European Center for Disease Prevention and Control (ECDC); 2019 February 2019.
2 Grulich AE, Guy R, Amin J, Jin F, Selvey C, Holden J, et al. Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study. Lancet HIV. 2018;5(11):e629–e37.
3 Kusejko K, Marzel A, Hampel B, Bachmann N, Nguyen H, Fehr J, et al. Quantifying the drivers of HIV transmission and prevention in men who have sex with men: a population model-based analysis in Switzerland. HIV Med. 2018;19(10):688–97.
4 Bundesamt für Gesundheit (BAG). HIV, Syphillis, Gonorrhoe und Chlamydiose in der Schweiz 2018: ein epidemiologische Übersicht. BAG-Bulletin 41. 2019.
5 Riddell Jt, Amico KR, Mayer KH. HIV Preexposure Prophylaxis: A Review. JAMA. 2018;319(12):1261–8.
6 Eidgenössischen Kommission für sexuelle Gesundheit (EKSG). Empfehlungen der Eidgenössischen Kommission für sexuelle Gesundheit (EKSG) zur HIV PräExpositionsprophylaxe (PrEP) in der Schweiz BAG-Bulletin 4, Januar 2016: Bundesamt für Gesundheit (BAG); 2016 [
7 Cottrell ML, Yang KH, Prince HM, Sykes C, White N, Malone S, et al. A Translational Pharmacology Approach to Predicting Outcomes of Preexposure Prophylaxis Against HIV in Men and Women Using Tenofovir Disoproxil Fumarate With or Without Emtricitabine. J Infect Dis. 2016;214(1):55–64.
8 Mugwanya KK, Baeten JM. Safety of oral tenofovir disoproxil fumarate-based pre-exposure prophylaxis for HIV prevention. Expert Opin Drug Saf. 2016;15(2):265–73.
9 Schmidt AJ, Rasi M, Esson C, Christinet V, Ritzler M, Lung T, et al. The Swiss STAR trial – an evaluation of target groups for sexually transmitted infection screening in the sub-sample of men. Swiss Med Wkly. 2020;150:w20392.
10 Sarit A. Golub SP, Rachel A. Fikslin, Matthew Goldberg, Asa Radix. Partners, Not Condom Use, Drive STI Rates Among Prep Users In Community Health Center Conference on Retroviruses and Opportunistic Infections (CROI): Conference on Retroviruses and Opportunistic Infections (CROI); 2018 [Available from:
http://www.croiconference.org/sessions/partners-not-condom-use-drive-sti-rates-among-prep-users-community-health-center.
11 Hampel B, Kusejko K, Braun DL, Harrison-Quintana J, Kouyos R, Fehr J. Assessing the need for a pre-exposure prophylaxis programme using the social media app Grindr(R). HIV Med. 2017;18(10):772–6.
12 The EMIS Network. EMIS-2017 – The European Men-Who-Have-Sex-With-Men Internet Survey. Key findings from 50 countries;
www.emis2017.eu; 2019.